Civic Intelligence

Sentinel Node Oncology Foundation

990EZ • Fiscal year 2008 • EIN 20-0173930

Jan 01, 2008 to Dec 31, 2008

Novato, CA
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

78th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2008 filings • 501(c)3 • <$500k nonprofits • Source year 2008

Liabilities / Revenue

77th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2008 filings • 501(c)3 • <$500k nonprofits • Source year 2008

Net Margin

83rd percentile

40%

Higher net margin than 83% of similar nonprofits.

2008 filings • 501(c)3 • <$500k nonprofits • Source year 2008

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2008

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2008

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2008

Assets

$45,693

No earlier filing loaded for comparison.

Net Assets

-

No earlier filing loaded for comparison.

Liabilities

$0

No earlier filing loaded for comparison.

Revenue

$43,975

No earlier filing loaded for comparison.

Expenses

$26,517

No earlier filing loaded for comparison.

Net Income

$17,458

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$300K$200K$100K$0Assets 2008: $45,693Liabilities 2008: $02008Assets 2013: $147,929Liabilities 2013: $0Net Assets 2013: $147,9292013Assets 2014: $157,429Liabilities 2014: $0Net Assets 2014: $157,4292014Assets 2015: $185,476Liabilities 2015: $4,353Net Assets 2015: $181,1232015Assets 2016: $245,028Liabilities 2016: $6,804Net Assets 2016: $238,2242016Assets 2017: $209,710Liabilities 2017: $25Net Assets 2017: $209,6852017Assets 2018: $260,756Liabilities 2018: $6,383Net Assets 2018: $254,3732018Assets 2019: $281,173Liabilities 2019: $673Net Assets 2019: $280,5002019Assets 2020: $0Liabilities 2020: $0Net Assets 2020: $02020Assets 2021: $0Liabilities 2021: $0Net Assets 2021: $02021Assets 2022: $258,008Liabilities 2022: $604Net Assets 2022: $257,4042022Assets 2023: $218,610Liabilities 2023: $500Net Assets 2023: $218,1102023Assets 2024: $196,494Liabilities 2024: $11,791Net Assets 2024: $184,7032024

Highlighted filing

2008

Assets$45,693
Liabilities$0
Net Assets-

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$200K$150K$100K$50K$0-$50KRevenue 2008: $43,975Expenses 2008: $26,517Net Income 2008: $17,4582008Revenue 2013: $132,427Expenses 2013: $69,728Net Income 2013: $62,6992013Revenue 2014: $5,446Expenses 2014: $11,075Net Income 2014: -$5,6292014Revenue 2015: $17,475Expenses 2015: $18,707Net Income 2015: -$1,2322015Revenue 2016: $152,112Expenses 2016: $74,440Net Income 2016: $77,6722016Revenue 2017: $145,216Expenses 2017: $132,106Net Income 2017: $13,1102017Revenue 2018: $53,299Expenses 2018: $15,705Net Income 2018: $37,5942018Revenue 2019: $147,646Expenses 2019: $148,632Net Income 2019: -$9862019Revenue 2020: $9,027Expenses 2020: $14,977Net Income 2020: -$5,9502020Revenue 2021: $13,074Expenses 2021: $18,336Net Income 2021: -$5,2622021Revenue 2022: $15,355Expenses 2022: $16,871Net Income 2022: -$1,5162022Revenue 2023: $51,026Expenses 2023: $90,320Net Income 2023: -$39,2942023Revenue 2024: $20,366Expenses 2024: $48,110Net Income 2024: -$27,7442024

Highlighted filing

2008

Revenue$43,975
Expenses$26,517
Net Income$17,458
Filing Detail Status

This 2008 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2008 to Dec 31, 2008
Mission and Program Overview

Mission

To Advance the care and treatment of patients with solid cancer, and to develop new preventative strategies, diagnosis and treatemnts.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings